These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34166229)

  • 1. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
    Zuo Y; Yalavarthi S; Navaz SA; Hoy CK; Harbaugh A; Gockman K; Zuo M; Madison JA; Shi H; Kanthi Y; Knight JS
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34166229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
    Zuo Y; Yalavarthi S; Navaz S; Hoy C; Harbaugh A; Gockman K; Zuo M; Madison JA; Shi H; Kanthi Y; Knight JS
    medRxiv; 2021 Jun; ():. PubMed ID: 33851189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome.
    Zuo Y; Yalavarthi S; Gockman K; Madison JA; Gudjonsson JE; Kahlenberg JM; Joseph McCune W; Bockenstedt PL; Karp DR; Knight JS
    Arthritis Rheumatol; 2020 Dec; 72(12):2130-2135. PubMed ID: 32729667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-released enzymes can influence composition of circulating immune complexes in multiple sclerosis.
    Paryzhak S; Dumych T; Mahorivska I; Boichuk M; Bila G; Peshkova S; Nehrych T; Bilyy R
    Autoimmunity; 2018 Sep; 51(6):297-303. PubMed ID: 30369266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.
    Zuo Y; Estes SK; Ali RA; Gandhi AA; Yalavarthi S; Shi H; Sule G; Gockman K; Madison JA; Zuo M; Yadav V; Wang J; Woodard W; Lezak SP; Lugogo NL; Smith SA; Morrissey JH; Kanthi Y; Knight JS
    Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33139519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity.
    Torres-Ruiz J; Absalón-Aguilar A; Nuñez-Aguirre M; Pérez-Fragoso A; Carrillo-Vázquez DA; Maravillas-Montero JL; Mejía-Domínguez NR; Llorente L; Alcalá-Carmona B; Lira-Luna J; Núñez-Álvarez C; Juárez-Vega G; Meza-Sánchez D; Hernández-Gilsoul T; Tapia-Rodríguez M; Gómez-Martín D
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
    Zuo Y; Navaz S; Tsodikov A; Kmetova K; Kluge L; Ambati A; Hoy CK; Yalavarthi S; de Andrade D; Tektonidou MG; Sciascia S; Pengo V; Ruiz-Irastorza G; Belmont HM; Gerosa M; Fortin PR; de Jesus GR; Branch DW; Andreoli L; Rodriguez-Almaraz E; Petri M; Cervera R; Willis R; Karp DR; Li QZ; Cohen H; Bertolaccini ML; Erkan D; Knight JS;
    Arthritis Rheumatol; 2023 Aug; 75(8):1407-1414. PubMed ID: 36862141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms.
    Mantej J; Bednarek M; Sitko K; Świętoń M; Tukaj S
    Cell Stress Chaperones; 2021 Jul; 26(4):735-740. PubMed ID: 34080135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.
    Middleton EA; He XY; Denorme F; Campbell RA; Ng D; Salvatore SP; Mostyka M; Baxter-Stoltzfus A; Borczuk AC; Loda M; Cody MJ; Manne BK; Portier I; Harris ES; Petrey AC; Beswick EJ; Caulin AF; Iovino A; Abegglen LM; Weyrich AS; Rondina MT; Egeblad M; Schiffman JD; Yost CC
    Blood; 2020 Sep; 136(10):1169-1179. PubMed ID: 32597954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.
    Lood C; Hughes GC
    Rheumatology (Oxford); 2017 Apr; 56(4):638-643. PubMed ID: 27354687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis.
    de Bont CM; Stokman MEM; Faas P; Thurlings RM; Boelens WC; Wright HL; Pruijn GJM
    J Autoimmun; 2020 Sep; 113():102484. PubMed ID: 32451286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
    J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.